Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine IV then Oral in Liver Transplant
NCT00332462Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2006
- Primary completion
- Apr 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine in Liver transplant rejection, sponsored by Novartis. Primary endpoint: Incidence of Biopsy Proven Acute Rejection at 3 months. Started May 2006; status: completed.
02
Drugs
cyclosporine
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00332462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332462.